FDA Warning Letter — American Fertility Medical Center - Genetic Infertility & Andrology Laboratory, Inc.
The FDA took a Warning Letter action against American Fertility Medical Center - Genetic Infertility & Andrology Laboratory, Inc. on April 2, 2020 (Irvine, CA). The action was issued by CBER and concerns biologics products. This facility has 3 recent FDA inspections on record.
Action Details
- Facility
- American Fertility Medical Center - Genetic Infertility & Andrology Laboratory, Inc.
- Date
- April 2, 2020
- Fiscal Year
- 2020
- Product Type
- Biologics
- Center
- CBER
- Location
- Irvine, CA (United States)